Clinical Trial: MSCohi-O Lenses for Ocular Involvement in Sjogren's Syndrome

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185139) titled 'MSCohi-O Lenses for Ocular Involvement in Sjogren's Syndrome' on Sept. 09.

Brief Summary: This study is aSingle-center, multiple-dosing, prospective, nonrandom, single-arm trial.

Study Start Date: Sept. 12

Study Type: INTERVENTIONAL

Condition: Sjogren's Syndrome

Intervention: DRUG: MSCohi-O Lenses

Each subject will wear MSCohi-O Lenses for 12 hours a day, totally 14 wearings.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....